Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Clicks: 410
ID: 120397
2006
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The response and remission rates in this highly generalizable sample with substantial axis I and axis III comorbidity closely resemble those seen in 8-week efficacy trials. The systematic use of easily implemented measurement-based care procedures may have assisted in achieving these results.
Reference Key
mh2006theevaluation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Trivedi MH;Rush AJ;Wisniewski SR;Nierenberg AA;Warden D;Ritz L;Norquist G;Howland RH;Lebowitz B;McGrath PJ;Shores-Wilson K;Biggs MM;Balasubramani GK;Fava M; ;;
Journal the american journal of psychiatry
Year 2006
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16390886&dopt=Abstract
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support female male N.I.H. Extramural Depressive Disorder Major / epidemiology adolescent middle aged Comorbidity Drug Administration Schedule Comparative Study Clinical Trial Multicenter Study dose-response relationship drug chronic disease psychiatric status rating scales / statistics & numerical data phase i mental disorders / epidemiology secondary prevention madhukar h trivedi ambulatory care major / drug therapy* a john rush major / diagnosis pmid:16390886 doi:10.1176/appi.ajp.163.1.28 star*d study team citalopram / therapeutic use* personality inventory serotonin uptake inhibitors / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.